Scythian logo.jpg
Scythian Biosciences Announces Appointment of Professor Michael Barnes as Chief Medical Officer
February 15, 2018 08:20 ET | Scythian Biosciences Corp.
- Influential voice in medical cannabis policy in Europe  - A leading world authority in neurological rehabilitation TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the...
Scythian logo.jpg
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell
February 14, 2018 08:30 ET | Scythian Biosciences Corp.
TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF)  is pleased to announce that the Company has received...
Scythian logo.jpg
Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace
January 10, 2018 09:00 ET | Scythian Biosciences Corp.
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has been upgraded to the...
Scythian logo.jpg
Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee
December 11, 2017 17:07 ET | Scythian Biosciences Corp.
TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has appointed Ottis...
Scythian logo.jpg
Scythian Biosciences Corp. Completes Sale of Go Green 
November 30, 2017 09:00 ET | Scythian Biosciences Corp.
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has entered into a...
Scythian logo.jpg
Scythian Retains Investor Relations Services
October 18, 2017 17:00 ET | Scythian Biosciences Corp.
TORONTO, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that is has entered into an agreement with...
Scythian logo.jpg
Scythian Biosciences Corp. Forms Professional Athlete Advisory Committee
September 27, 2017 17:00 ET | Scythian Biosciences Corp.
TORONTO, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company") (TSX-V:SCYB) is pleased to announce the formation of its Professional Athlete Advisory Committee. The purpose...
IBRI no background.jpg
Indiana Biosciences Research Institute Names Dr. Rainer Fischer CEO
August 31, 2017 16:04 ET | Indiana Biosciences Research Institute
INDIANAPOLIS, Aug. 31, 2017 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced that it has named current Chief Scientific and Innovation Officer Rainer Fischer,...
Scythian logo.jpg
Scythian Biosciences Corp. Retains Hybrid Financial Ltd. for Investor Relations Activities
August 17, 2017 09:24 ET | Scythian Biosciences Corp.
TORONTO, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company”) (TSXV:SCYB) announces that it has retained the services of Hybrid Financial Ltd. (”Hybrid Financial”) for...
Funding From Alzheimer’s Drug Discovery Foundation Advances M3 Biotechnology Toward Human Trials
April 13, 2017 20:00 ET | M3 Biotechnology
SEATTLE, April 13, 2017 (GLOBE NEWSWIRE) -- As the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug...